Evidence map›Paper›PMID 29681545›Full record

ArticleStem cell reports2018

NF-κB Activity Initiates Human ESC-Derived Neural Progenitor Cell Differentiation by Inducing a Metabolic Maturation Program.

Lorna M FitzPatrick, Kate E Hawkins, Juliette M K M Delhove, Emilio Fernandez, Chiara Soldati, Louise F Bullen, Axel Nohturfft, Simon N Waddington, Diego L Medina, Juan P Bolaños and 1 more

Abstract read
In one paragraph

Article in Stem cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lorna M FitzPatrickSchool of Healthcare Sciences, Manchester Metropolitan University, Manchester M1 5GD, UK; Stem Cell Group, Cardiovascular & Cell Sciences Research Institute, St. George's University of London, Cranmer Terrace, London SW17 0RE, UK. Electronic address: l.fitzpatrick@mmu.ac.uk.
Kate E HawkinsStem Cell Group, Cardiovascular & Cell Sciences Research Institute, St. George's University of London, Cranmer Terrace, London SW17 0RE, UK.
Juliette M K M DelhoveStem Cell Group, Cardiovascular & Cell Sciences Research Institute, St. George's University of London, Cranmer Terrace, London SW17 0RE, UK.
Emilio FernandezInstitute of Functional Biology and Genomics, University of Salamanca-CSIC, 37007 Salamanca, Spain; Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, 37007 Salamanca, Spain.
Chiara SoldatiTelethon Institute of Genetics and Medicine, Via Campi Flegrei 34, Pozzuoli, Naples 80078, Italy.
Louise F BullenSchool of Healthcare Sciences, Manchester Metropolitan University, Manchester M1 5GD, UK.
Axel NohturfftStem Cell Group, Cardiovascular & Cell Sciences Research Institute, St. George's University of London, Cranmer Terrace, London SW17 0RE, UK.
Simon N WaddingtonGene Transfer Technology Group, Institute for Women's Health, University College London, 86-96 Chenies Mews, London WC1E 6HX, UK; MRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of Witswatersrand, Johannesburg, South Africa.
Diego L MedinaTelethon Institute of Genetics and Medicine, Via Campi Flegrei 34, Pozzuoli, Naples 80078, Italy.
Juan P BolañosInstitute of Functional Biology and Genomics, University of Salamanca-CSIC, 37007 Salamanca, Spain; Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, 37007 Salamanca, Spain.
Tristan R McKaySchool of Healthcare Sciences, Manchester Metropolitan University, Manchester M1 5GD, UK; Stem Cell Group, Cardiovascular & Cell Sciences Research Institute, St. George's University of London, Cranmer Terrace, London SW17 0RE, UK.

Funding

European Research Council 260862Medical Research Council G1000709Medical Research Council MR/N019075/1Medical Research Council MR/N026101/1Medical Research Council MR/P026494/1Medical Research Council MR/R015325/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/L001780/1
6 · The paper itself

Abstract

Human neural development begins at embryonic day 19 and marks the beginning of organogenesis. Neural stem cells in the neural tube undergo profound functional, morphological, and metabolic changes during neural specification, coordinated by a combination of exogenous and endogenous cues. The temporal cell signaling activities that mediate this process, during development and in the postnatal brain, are incompletely understood. We have applied gene expression studies and transcription factor-activated reporter lentiviruses during in vitro neural specification of human pluripotent stem cells. We show that nuclear factor κB orchestrates a multi-faceted metabolic program necessary for the maturation of neural progenitor cells during neurogenesis.

Indexed as

Cell DifferentiationEnergy MetabolismAutophagyBiomarkersCell CycleCells, CulturedComputational BiologyEmbryonic Stem CellsGene Expression ProfilingGene OntologyHumansImmunohistochemistryModels, BiologicalNeural Stem CellsNeurogenesisNF-kappa BBiomarkersNF-kappa Bautophagycell cyclehuman embryonic developmentmetabolismneurogenesisNF-κB signaling

Identifiers

PMID29681545
PMCPMC5989595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.